Skip to content
Bored Studies
RecruitingEarly Phase 1

A Phase 1 Study of ARC-001 in Participants Undergoing Third Molar Extraction

Arcato Laboratories, Inc. · NCT06864884

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–55 · All sexes
Healthy volunteers
Not accepted (a condition is required)
Study type
Interventional · Early Phase 1
Target enrollment
30
US sites recruiting
1
Study start
February 26, 2025
Record last updated
March 11, 2025

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The study will test the investigational product gel against placebo (which contains no active ingredient) to determine if it is safe after wisdom tooth extraction. The main questions the study will answer are:

  • How much of the investigational product is absorbed in the blood?
  • Are there side effects?

Being studied: ARC-001; Placebo gel

Conditions: Acute Post Operative Pain; Third Molar Extraction Surgery

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Able to provide informed consent
  • In generally good health
  • BMI 18 to 38kg/m²
  • Scheduled to undergo wisdom teeth extraction

Exclusion Criteria

  • Serious medical condition
  • Clinically significant abnormal lab values
  • Blood donation in the last 60 days, or plasma donation in the last 7 days.

Recruiting US locations

  • CenExel JBR

    Salt Lake City, UT 84107

    Site contact: Recruiter · 801-261-2000 · participate@jbrutah.com

All phase 1 studies in Utah →
A Phase 1 Study of ARC-001 in Participants Undergoing Third Molar… (NCT06864884) | Bored Studies